tech
Investors bet on AI drug discovery despite approval gap
US specialist venture firm Dimension Capital raises $800mn fund to back AI-designed medicines
TL;DR
- Dimension Capital has raised an $800 million fund.
- The fund will support AI-designed medicines.
- This investment highlights confidence in AI within the pharmaceutical industry.